US pharma company Eli Lilly pauses trial of antibody drug Trump touted as COVID-19 'cure'

Sydney Morning Herald

13 Oct 2020 0 shares 1 views

US pharma company Eli Lilly pauses trial of antibody drug Trump touted as COVID-19 'cure'

Sydney Morning Herald

Published 13 Oct 2020

The announcement comes one day after Johnson & Johnson said it was forced to pause a large high-profile trial of its experimental coronavirus vaccine because a volunteer fell ill.

Full Article

Related news coverage

Long Road Ahead To COVID-19 Immunity Even With Vaccines – OpEd

Eurasia Review 08 Oct 2020

By Prabir Purkayastha*

As the pandemic continues to spread throughout the world, many countries seem to have given up..

Regeneron halts antibody trial in seriously ill Covid patients
FT.com 30 Oct 2020
Eli Lilly wins US$375mln US government order for COVID-19 drug
Proactive Investors 28 Oct 2020
Tetra Bio-Pharma inks research deal to study ARDS-003 in coronavirus animal model
Proactive Investors 22 Oct 2020
US pharma company Eli Lilly pauses trial of antibody drug Trump touted as COVID-19 'cure' over safety concern
The Age 13 Oct 2020

US pharma company Eli Lilly pauses trial of antibody drug Trump touted as COVID-19 'cure'

US pharma company Eli Lilly pauses trial of antibody drug Trump touted as COVID-19 'cure'

You might like

Related news coverage

Long Road Ahead To COVID-19 Immunity Even With Vaccines – OpEd

Advertisement